Published in Blood Weekly, February 15th, 1999
A University of Michigan (UM) team in Ann Arbor, has found that a natural substance known as vascular endothelial growth factor (VEGF) contributes to angiogenesis not only by stimulating blood vessel growth, but also by prolonging the survival of blood vessel cells.
This finding has important implications for understanding how angiogenesis contributes to tumors and chronic inflammatory diseases such as rheumatoid arthritis and psoriasis. It also may help researchers develop strategies for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.